BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 26716602)

  • 1. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.
    Ting DS; Cheung GC; Wong TY
    Clin Exp Ophthalmol; 2016 May; 44(4):260-77. PubMed ID: 26716602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy.
    Sabanayagam C; Yip W; Ting DS; Tan G; Wong TY
    Ophthalmic Epidemiol; 2016 Aug; 23(4):209-22. PubMed ID: 27355693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence.
    Wong TY; Sabanayagam C
    Ophthalmologica; 2020; 243(1):9-20. PubMed ID: 31408872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current epidemiology of diabetic retinopathy and diabetic macular edema.
    Ding J; Wong TY
    Curr Diab Rep; 2012 Aug; 12(4):346-54. PubMed ID: 22585044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
    Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
    Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing risk factors, screening, and preventative treatment for diabetic retinopathy in developing countries: a review.
    Lin S; Ramulu P; Lamoureux EL; Sabanayagam C
    Clin Exp Ophthalmol; 2016 May; 44(4):300-20. PubMed ID: 26991970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management.
    Lin T; Gubitosi-Klug RA; Channa R; Wolf RM
    Curr Diab Rep; 2021 Dec; 21(12):56. PubMed ID: 34902076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service.
    Thomas RL; Dunstan FD; Luzio SD; Chowdhury SR; North RV; Hale SL; Gibbins RL; Owens DR
    Br J Ophthalmol; 2015 Jan; 99(1):64-8. PubMed ID: 25091950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and public health strategies for diabetic retinopathy in the Eastern Mediterranean region.
    Khandekar R
    Middle East Afr J Ophthalmol; 2012; 19(2):178-84. PubMed ID: 22623855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for diabetic retinopathy].
    Hartstra WW; Holleman F; Hoekstra JB; Schlingemann RO
    Ned Tijdschr Geneeskd; 2007 Jan; 151(4):228-33. PubMed ID: 17323877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic retinopathy in pregnancy: a review.
    Morrison JL; Hodgson LA; Lim LL; Al-Qureshi S
    Clin Exp Ophthalmol; 2016 May; 44(4):321-34. PubMed ID: 27062093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability and variability in guidelines on diabetic retinopathy screening in Asian countries.
    Wang LZ; Cheung CY; Tapp RJ; Hamzah H; Tan G; Ting D; Lamoureux E; Wong TY
    Br J Ophthalmol; 2017 Oct; 101(10):1352-1360. PubMed ID: 28292772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy and ocular co-morbidities among persons with diabetes at Sumail Hospital of Oman.
    Khandekar RB; Tirumurthy S; Al-Harby S; Moorthy NS; Amir I
    Diabetes Technol Ther; 2009 Oct; 11(10):675-9. PubMed ID: 19821761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of diabetic retinopathy at first presentation to the retinal screening service in the greater Wellington region of New Zealand 2006-2015, and implications for models of retinal screening.
    Chang LY; Lee AC; Sue W
    N Z Med J; 2017 Feb; 130(1450):78-88. PubMed ID: 28207727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowering the risk of visual impairment and blindness.
    Cunha-Vaz J
    Diabet Med; 1998; 15 Suppl 4():S47-50. PubMed ID: 9868992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of diabetic retinopathy in Norway: report from a screening study.
    Kilstad HN; Sjølie AK; Gøransson L; Hapnes R; Henschien HJ; Alsbirk KE; Fossen K; Bertelsen G; Holstad G; Bergrem H
    Acta Ophthalmol; 2012 Nov; 90(7):609-12. PubMed ID: 21955522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-year prevalence and incidence of diabetic retinopathy and cost-effectiveness of tele-ophthalmology in Manitoba.
    Kanjee R; Dookeran RI; Mathen MK; Stockl FA; Leicht R
    Can J Ophthalmol; 2016 Dec; 51(6):467-470. PubMed ID: 27938959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.